Sarepta Therapeutics | SRPT - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Capricor Therapeutics 2.76K 2.76K 2022-12
Daiichi Sankyo 20.73 1.74 2025-12
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novavax 2.01 1.07 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 11.84 0.14 2026-03
Sarepta Therapeutics 27.27 0 2025-09
Tectonic Therapeutic 4.01 0.63 2024-03
Vertex Pharmaceuticals 25.82 0.33 2026-03